Stephanie Davis, an analyst from Barclays, maintained the Sell rating on WW International (WW – Research Report). The associated price ...

WW International ( NASDAQ: WW ), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...

WW International Inc (WW) stock saw a modest uptick, ending the day at $0.75 which represents a slight increase of $0.03 or 4.17% from the prior close of $0.72. The stock opened at $0.73 and touched a ...

WW International has removed CEO Sima Sistani from the chief executive role effective immediately, the company previously ...

Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss drugs to its members.

With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management ...

Pan-European indie group Vuelta, which recently bought Telepool in Germany, has completed another strategic acquisition with ...

The executive led the diet company, better known as WeightWatchers, since 2022 into the burgeoning market for obesity drugs.

Sept. 28 (UPI) --WW International has removed CEO Sima Sistani from the chief executive role effective immediately, the company previously known as Weight Watchers said in a statement. Sistani ...

On Monday, WW International Inc (WW) stock saw a modest uptick, ending the day at $0.88 which represents a slight increase of $0.05 or 6.02% from the prior close of $0.83. The stock opened at $0.82 ...

Barclays analyst Stephanie Davis assigned a Sell rating to WW International (WW – Research Report) today and set a price target of $0.75.